Screener
XPH vs KIE
State Street SPDR S&P Pharmaceuticals ETF vs State Street SPDR S&P Insurance ETF
Side-by-side comparison
| XPH | KIE | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $355M | $453M |
| Since | 2006 | 2005 |
| Dividend yield | 0.65% | 1.62% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +47.4% | +0.9% |
| CAGR 3Y | +14.1% | +15.0% |
| CAGR 5Y | +4.7% | +9.6% |
| Sharpe 3Y | 0.58 | 0.71 |
| Volatility 1Y | 21.28% | 16.17% |
| Max drawdown | -35.96% | -44.31% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XPH and KIE
Explore further